Rinatabart Sesutecan

Rinatabart Sesutecan · Genmab

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rinatabart Sesutecan, covering 2026-04-07 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) [Phase 1, Phase 2]

See pricing